CLEC16A and autoimmune disease: The study of Kim and colleagues [96] suggests that CLEC16A might confer susceptibility to autoimmune disorders through its role in endosomal regulation of immune receptor signaling pathways, leading to aberrant immune responses of autoreactive T-cells.